ConvaTec stock rises 0.37 percent in London trading

Published on 09/22/2026 at 20:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ConvaTec stock traded at 214.80 GBX on September 22, 2026, up 0.37 percent. Fiscal 2025 revenue reached GBP 2.439 billion, versus GBP 2.289 billion in 2024.

Moderne Medizintechnik-Reinraumfertigung mit Technikern an steriler Produktionslinie — ConvaTec Group Plc GB00BD3VFW73 zeigt moderne Medizintechnik-Fertigung mit sterilen Produktionslinien und Reinraumtechnikern, Illustration mit AI erstellt.

ConvaTec stock traded at 214.80 GBX on the London Stock Exchange on September 22, 2026, up 0.37 percent from the previous close. The move followed a September 21 close of 214.00 GBX, when the shares fell 2.1 percent on volume of about 14.78 million shares.

Revenue reached GBP 2.439 billion

According to Reuters data dated September 22, 2026, ConvaTec reported fiscal 2025 revenue of GBP 2.439 billion, compared with GBP 2.289 billion in fiscal 2024. That represents an increase of GBP 149.8 million, or about 6.5 percent, making revenue growth the clearest operating comparison in the available figures.

The same fiscal 2025 data show gross profit of GBP 1.384 billion and net income of GBP 175 million, compared with GBP 1.299 billion and GBP 190.5 million respectively in fiscal 2024. Revenue and gross profit increased, while net income declined by GBP 15.5 million, a contrast that places greater weight on margin quality and cost control.

London price remains the key signal

The September 22 quotation stood between the reported intraday low of 213.80 GBX and high of 217.00 GBX, with 565,788 shares traded at the cited market-data timestamp. The prior close was 214.80 GBX in the Reuters quotation record, while the London market overview showed 214.80 GBX, a day high of 216.00 GBX, a low of 212.80 GBX, a gain of 0.80 GBX and volume of 3.56 million shares at 11:35:59.

The comparison with September 21 is important: the stock moved from a 2.1 percent loss to a 0.37 percent gain in the next session. That reversal describes a change in short-term trading direction, but it does not by itself establish a new trend or alter the longer-term earnings picture.

Fiscal figures frame the valuation debate

ConvaTec's fiscal 2025 net income of GBP 175 million was below the GBP 190.5 million recorded in fiscal 2024, even as revenue rose from GBP 2.289 billion to GBP 2.439 billion. For investors, the central calculation is therefore whether the additional revenue can translate into sustained profit improvement rather than only higher sales.

MarketScreener listed 19 analysts in its September 22, 2026 consensus display and showed an average target price of USD 4.052, alongside a mean consensus of Buy. Those figures are presented in US dollars on the portal and are not used as a reference price for the London-listed shares, which remain quoted in GBX.

ConvaTec stock closes at 214.80 GBX

ConvaTec stock was quoted at 214.80 GBX on the London Stock Exchange as of September 22, 2026, with a daily change of 0.37 percent. The next market reading will be judged against the combination of fiscal 2025 revenue growth and the decline in reported net income.